- $762.64m
- $480.55m
- €53.76m
- 41
- 17
- 30
- 19
Annual balance sheet for CureVac NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 31.1 | 1,323 | 813 | 498 | 404 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 18.7 | 4.01 | 21.2 | 11.6 | 23 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 57.2 | 1,390 | 940 | 584 | 478 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 61.7 | 101 | 200 | 242 | 279 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 131 | 1,511 | 1,158 | 860 | 788 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 28.1 | 248 | 358 | 156 | 186 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 173 | 800 | 470 | 327 | 271 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -42.8 | 711 | 688 | 533 | 517 |
Total Liabilities & Shareholders' Equity | 131 | 1,511 | 1,158 | 860 | 788 |
Total Common Shares Outstanding |